Chimeric antigen receptor-natural killer cell therapy in first-relapse epithelial ovarian cancer: an early health-economic evaluation in the Netherlands. - Seyahian A; Scholte M; Gravesteijn C; Zusterzeel PLM; De Jonge PKJD; de Goede A; Jansen JH; Bekkers RLM; Ottevanger PB; Dolstra H; Grutters JPC (Cytotherapy, 2026)